___

• 1. Mattson, M.P., Arumugam T.V. (2018). Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metabolism, 27(6), 1176–1199. [CrossRef]
• 2. Alexander, G.E., Ryan, L., Bowers, D., Foster, T.C., Bizon, J.L., Geldmacher, D.S., Glisky, E.L. (2012). Characterizing cognitive aging in humans with links to animal models. Frontiers in Aging Neuroscience, 4, 21. [CrossRef]
• 3. Dykiert, D., Der, G., Starr, J.M., Deary, I.J. (2012). Age differences in intra-individual variability in simple and choice reaction time: systematic review and meta-analysis. PLoS One, 7(10), e45759. [CrossRef]
• 4. Levin, O., Fujiyama, H., Boisgontier, M.P., Swinnen, S.P., Summers, J.J. (2014). Aging and motor inhibition: a converging perspective provided by brain stimulation and imaging approaches. Neuroscience and Biobehavioral Reviews, 43, 100-117. [CrossRef]
• 5. Aarsland, D., Creese, B., Politis, M., Chaudhuri, K.R., Ffytche, D.H., Weintraub, D., Ballard, C. (2017). Cognitive decline in parkinson disease. Nature Reviews Neurology, 13(4), 217-231. [CrossRef]
• 6. Kalia, L. V., Lang, A. E. (2015). Parkinson's disease. Lancet, 386(9996), 896-912. [CrossRef]
• 7. Mattson, M.P. (2004). Pathways towards and away from alzheimer's disease. Nature, 430(7000), 631-639. [CrossRef]
• 8. Scheltens, P., Blennow, K., Breteler, M.M., de Strooper, B., Frisoni, G.B., Salloway, S., Van der Flier, W.M. (2016). Alzheimer's disease. Lancet, 388(10043), 505-517. [CrossRef]
• 9. Isaev, N.K., Stelmashook, E.V., Stelmashook, N.N., Sharonova, I.N., Skrebitsky, V.G. (2013). Brain aging and mitochondria-targeted plastoquinone antioxidants of SkQ-type. Biochemistry (Mosc), 78(3), 295-300. [CrossRef]
• 10. Isaev, N.K., Stelmashook, E.V., Genrikhs, E.E. (2019). Neurogenesis and brain aging. Rev Neurosci, 30(6), 573-580. [CrossRef]
• 11. Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., Abete, P. (2018). Oxidative stress, aging, and diseases. Clinical Interventions in Aging., 13, 757-72. [CrossRef]
• 12. Ionescu-Tucker, A., Cotman, C.W. (2021). Emerging roles of oxidative stress in brain aging and alzheimer’s disease. Neurobiology of Aging., 107, 86-95. [CrossRef]
• 13. Butterfield, D.A., Howard, B.J., LaFontaine, M.A. (2001). Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, alzheimer’s disease and huntington’s disease. Current Medicinal Chemistry, 8(7), 815-28. [CrossRef]
• 14. Zhang, Y., Ding, C., Cai, Y., Chen, X., Zhao, Y., Liu, X., Zhang, J., Sun, S., Liu, W. (2021). Astilbin ameliorates oxidative stress and apoptosis in D-galactose-induced senescence by regulating the PI3K/Akt/m-TOR signaling pathway in the brains of mice. International Immunopharmacology, 99, 108035. [CrossRef]
• 15. Aydın, A.F., Çoban, J., Doğan-Ekici, I., Betül-Kalaz, E., Doğru-Abbasoğlu, S., Uysal, M.(2016). Carnosine and taurine treatments diminished brain oxidative stress and apoptosis in D-galactose aging model. Metabolic Brain Disease, 31(2), 337-45. [CrossRef]
• 16. Singh, S., Singh, A.K., Garg, G., Rizvi, S.I.(2018). Fisetin as a caloric restriction mimetic protects rat brain against aging induced oxidative stress, apoptosis and neurodegeneration. Life Sciences, 193, 171-179. [CrossRef]
• 17. Garg, G., Singh, S., Singh, A.K., Rizvi, S.I. (2018). N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. Canadian Journal of Physiology and Pharmacology, 96(12), 1189-1196. [CrossRef]
• 18. Wan, J.Z., Wang, R., Zhou, Z.Y., Deng, L.L., Zhang, C.C., Liu, C.Q., Zhao, H.X., Yuan, C.F., He, Y.M., Dun, Y.Y., Yuuan, D., Wang, T. (2020). Saponins of panax japonicus confer neuroprotection against brain aging through mitochondrial related oxidative stress and autophagy in rats. Current Pharmaceutical Biotechnology, 21(8), 667-680. [CrossRef]
• 19. Yang, C., DeMars, K.M., Candelario-Jalil, E. (2018). Age-dependent decrease in adropin is associated with reduced levels of endothelial nitric oxide synthase and increased oxidative stress in the rat brain. Aging and Disease, 9(2), 322-330. [CrossRef]
• 20. Alabarse, P.V.G., Hackenhaar, F.S., Medeiros, T.M., Mendes, M.F.A., Viacava, P.R., Schüller, A.K., Salomon, T.B., Ehrenbrink, G., Benfato, M.S. (2011). Oxidative stress in the brain of reproductive male rats during aging. Experimental Gerontology, 46(4), 241-8. [CrossRef]
• 21. Li, X., Chen, Y., Shao, S., Tang, Q., Chen, W., Chen, Y., Xu, X. (2016). Oxidative stress induces the decline of brain EPO expression in aging rats. Experimental Gerontology, 83, 89-93. [CrossRef]
• 22. Tatarkova , Z., Kovalska , M., Timkova, V., Racay,P., Lehotsky, J., Kaplan, P. (2016). The effect of aging on mitochondrial complex I and the extent of oxidative stress in the rat brain cortex. Neurochemical Research, 41(8), 2160-72. [CrossRef]
• 23. Navarro, A., Boveris, A. (2010). Brain mitochondrial dysfunction in aging, neurodegeneration, and parkinson's disease. Frontiers in Aging Neuroscience, 2, 34. [CrossRef]
• 24. Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., Strosznajder, J.B., Eckert, A., Müller, W. E. (2007). Mitochondrial dysfunction: the first domino in brain aging and alzheimer's disease? Antioxid Redox Signal., 9(10), 1659-75. [CrossRef]
• 25. Liu, H., Zhang, X., Xiao, J., Song, M., Cao, Y., Xiao, H., Liu, X. (2020). Astaxanthin attenuates d-galactose-induced brain aging in rats by ameliorating oxidative stress, mitochondrial dysfunction, and regulating metabolic markers. Food and Function, 11(5), 4103-4113. [CrossRef]
• 26. Boveris, A., Navarro, A. (2008). Brain mitochondrial dysfunction in aging. IUBMB Life, 60(5), 308-14. [CrossRef]
• 27. Li, Y., Yu, H., Chen, C., Li, S., Zhang, Z., Xu, H., Zhu, F., Liu, J., Spencer, P.S., Dai, Z., Yang, X. (2020). Proteomic profile of mouse brain aging contributions to mitochondrial dysfunction, DNA oxidative damage, loss of neurotrophic factor, and synaptic and ribosomal proteins. Oxidative Medicine Cellular Longevity, 5408452. [CrossRef]
• 28. Gauba, E., Guo, L., Du, H. (2017). Cyclophilin D promotes brain mitochondrial F1FO ATP synthase dysfunction in aging mice. Journal of Alzheimer's Disease, 55(4), 1351-1362. [CrossRef]
• 29. Klosinski, L.P., Yao, J., Yin, F., Fonteh, A.N., Harrington, M.G., Christensen, T.A., Trushina, E., Brinton, R.D. (2015). White matter lipids as a ketogenic fuel supply in aging female brain: implications for alzheimer's disease. EbioMedicine, 2(12), 1888-904. [CrossRef]
• 30. Brown, M.K., Naidoo, N. (2012). The endoplasmic reticulum stress response in aging and age-related diseases. Frontiers in Physiology, 3, 263. [CrossRef]
• 31. Anelli, T., Sitia, R. (2008). Protein quality control in the early secretory pathway.The EMBO Journal, 27(2), 315-27. [CrossRef]
• 32. Oakes, S.A., Papa, F.R. (2015). The role of endoplasmic reticulum stress in human pathology. Annual Review of Pathology, 10, 173-94. [CrossRef]
• 33. Wang, S., Kaufman, R. J. (2012). The impact of the unfolded protein response on human disease. The Journal of Cell Biology, 197(7), 857-67. [CrossRef]
• 34. Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P., Ron, D. (2000). Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nature Cell Biology, 2(6), 326-32. [CrossRef]
• 35. Ma, K., Vattem, K.M., Wek, R.C. (2002). Dimerization and release of molecular chaperone inhibition facilitate activation of eukaryotic initiation factor-2 kinase in response to endoplasmic reticulum stress. The Journal of Biological Chemistry, 277(21), 18728-35. [CrossRef]
• 36. Shen, J., Linda, X.C., Hendershot, L., Prywes, R. (2002). ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of golgi localization signals. Developmental Cell, 3(1), 99-111. [CrossRef]
• 37. Oakes, S. A. (2020). Endoplasmic reticulum stress signaling in cancer cells. The American Journal of Pathology, 190(5), 934-946. [CrossRef]
• 38. Taylor, R.C. (2016). Aging and the UPR(ER). Brain Research, 1648, 588-593. [CrossRef]
• 39. Oh, J.H., Nam, T.J. (2019). Hydrophilic glycoproteins of an edible green alga capsosiphon fulvescens prevent aging-induced spatial memory impairment by suppressing GSK-3β-Mediated ER stress in dorsal hippocampus. Marine Drugs, 17(3), 168. [CrossRef]
• 40. Naidoo, N, Ferber, M., Master, M., Zhu, Y., Pack, A.I. (2008). Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. The Journal of Neuroscience, 28(26), 6539-48. [CrossRef]
• 41. Naidoo, N., Zhu, J., Galante, R.J., Lian, J., Strus, E., Lee, A., Keenan, B.T., Pack, A.I. (2018). Reduction of the molecular chaperone binding immunoglobulin protein (BiP) accentuates the effect of aging on sleep-wake behavior. Neurobiology of Aging, 69, 10-25. [CrossRef]
• 42. Hussain, S.G., Ramaiah, K.V. (2007). Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochemical Biophysical Research Communications, 355, 365-370. [CrossRef]
• 43. Plaza-Zabala, A., Sierra-Torre, V., Sierra, A. (2017). Autophagy and microglia: novel partners in neurodegeneration and aging. International Journal of Molecular Sciences, 18(3), 598. [CrossRef]
• 44. Loeffler, D.A. (2019). Influence of normal aging on brain autophagy: a complex scenario. Frontiers in Aging Neuroscience, 11, 49. [CrossRef]
• 45. Liu, A.D., Guo, E.S., Yang, J.K., Yang, Y., Liu, S.P., Jiang, X.J., Hu, Q., Dirsch, O., Dahmen, U., Zhang, C.T., Gewirtz, D.A., Fang, H.S. (2018). Young plasma reverses age-dependent alterations in hepatic function through the restoration of autophagy. Aging Cell, 17(1), e12708. [CrossRef]
• 46. LaRocca, T.J., Henson, G.D., Thorburn, A., Sindler, A.L., Pierce, G.L., Seals, D.R. (2012). Translational evidence that impaired autophagy contributes to arterial ageing. Journal of Physiology-London, 590, 3305-3316. [CrossRef]
• 47. LaRocca, T.J., Gioscia-Ryan, R.A., Hearon, C.M., Seals, D.R. (2013). The autophagy enhancer spermidine reverses arterial aging. Mechanisms of Ageing and Development, 134, 314-320. [CrossRef]
• 48. Cao Y., Klionsky D.J. (2007). Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Research, 17, 839–849. [CrossRef]
• 49. Mizushima N., Yoshimori T., Levine B. (2010). Methods in mammalian autophagy research. Cell, 140, 313– 326. [CrossRef]
• 50. Shen, K., Liu, X., Chen, D., Chang, J., Zhang, Y., Kou, X. (2021). Voluntary wheel-running exercise attenuates brain aging of rats through activating miR-130a-mediated autophagy. Brain Research Bulletin, 172, 203-211. [CrossRef]
• 51. Cervellati, C., Trentini, A., Pecorelli, A., Valacchi, G. (2020). Inflammation in neurological disorders: the thin boundary between brain and periphery. Antioxidants Redox Signaling, 33(3), 191-210. [CrossRef]
• 52. Aguzzi, A., Barres, B.A., Bennett, M.L.(2013). Microglia: scapegoat, saboteur, or something else? Science, 339(6116), 156-61. [CrossRef]
• 53. Cribbs, D.H., Berchtold N.C., Perreau V., Coleman P.D., Rogers J., Tenner A.J., Cotman C.W. (2012). Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. Journal of Neuroinflammation, 9, 179. [CrossRef]
• 54. Norden, D.M., Godbout J.P. (2013). Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathology and Applied Neurobiology, 39, 19–34. [CrossRef]
• 55. Mosher K.I., Wyss-Coray T. (2014). Microglial dysfunction in brain aging and Alzheimer’s disease. Biochemical Pharmacology, 88, 594–604. [CrossRef]
• 56. Marschallinger, J., Iram, T., Zardeneta, M., Lee, S.E., Lehallier, B., Haney, M.S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D.W., Kim, J., Tevini, J., Felder, T.K., Wolinski, H., Bertozzi, C.R., Bassik, M.C., Aigner, L., Wyss-Coray, T. (2020). Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nature Neuroscience, 23(2), 194-208. [CrossRef]
• 57. Elahi, F.M., Harvey, D., Altendahl, M., Brathaban, N., Fernandes, N., Casaletto, K.B., Staffaroni, A.M., Maillard, P., Hinman, J.D., Miller, B.L., DeCarli, C., Kramer, J.H., Goetzl, E.J.(2021). Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans. Scientifik Reports, 11(1), 16198. [CrossRef]
• 58. Corlier, F., Hafzalla, G., Faskowitz, J., Kuller, L.H., Becker, J.T., Lopez, O.L., Thompson, P.M., Braskie, M.N. (2018). Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk. Neuroimage, 172, 118-129. [CrossRef]
• 59. Sala-Llonch, R., Idland, A.V., Borza, T., Watne, L.O., Wyller, T.B., Brækhus, A., Zetterberg, H., Blennow, K., Walhovd, K.B., Fjell, A.M. (2017). Inflammation, amyloid, and atrophy in the aging brain: relationships with longitudinal changes in cognition. Journal of Alzheimer’s Disease, 58(3), 829-840. [CrossRef]
• 60. Lindbergh, C.A., Casaletto, K.B., Staffaroni, A.M., Elahi, F., Walters, S.M., You, M., Neuhaus, J., Rivera Contreras, W., Wang, P., Karydas, A., Brown, J., Wolf, A., Rosen, H., Cobigo, Y., Kramer, J.H. (2020). Systemic tumor necrosis factor-alpha trajectories relate to brain health in typically aging older adults. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 75, 1558-1565. [CrossRef]
• 61. Spencer, S.J., D'Angelo, H., Soch, A., Watkins, L.R., Maier, S.F., Barrientos, R.M. (2017). High-fat diet and aging interact to produce neuroinflammation and impair hippocampal- and amygdalar-dependent memory. Neurobiology of Aging, 58, 88-101. [CrossRef]
• 62. Keller, J.N., Dimayuga, E., Chen, Q., Thorpe, J., Gee, J., Ding, Q. (2004). Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. The International Journal of Biochemistry Cell Biology, 36(12), 2376-91 [CrossRef]
• 63. Farout, L., Friguet, B. (2006). Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxidants Redox Signaling, 8(1-2), 205-16. [CrossRef]
• 64. Kukan, M. (2004). Emerging roles of proteasomes in ischemia-reperfusion injury of organs. Journal of Physiology and Pharmacology, 55(1 Pt 1), 3-15. [CrossRef]
• 65. Sun-Wang, J. L., Ivanova, S., Zorzano, A. (2020). The dialogue between the ubiquitin-proteasome system and autophagy: Implications in ageing. Ageing Research Reviews, 64, 101203. [CrossRef]
• 66. Eldeeb, M. A. (2021). N-Terminal-Dependent protein degradation and targeting cancer cells. Anticancer Agents in Medicinal Chemistry, 21(2), 231-236. [CrossRef]
• 67. Cao, J., Zhong, M.B., Taro, C.A., Zhang, L., Cai, D. (2019). Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis. Neuroscience Letters, 703, 68-78. [CrossRef]
• 68. Zucca, F.A., Vanna, R., Cupaioli, F.A., Bellei, C., Palma, A.D., Silvestre, D.D., Mauri, P., Grassi, S., Prinetti, A., Casella, L., Sulzer, D., Zecca, L. (2018). Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease. NPJ Parkinson’s Disease, 4, 17. [CrossRef]
• 69. Pao, P.C., Patnaik, D., Watson, L.A., Gao, F., Pan, L., Wang, L., Adaikkan, C., Penney, J., Cam, H.P., Huang, W.C., Pantano, L., Lee, A., Nott, A., Phan, T. X., Gjoneska, E., Elmsaouri, S., Haggarty, S. J., Tsai, L.H. (2020). HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease. Nature Communications, 11(1), 2484. [CrossRef]
• 70. Tse, K.H., Herrup, K. (2017). DNA damage in the oligodendrocyte lineage and its role in brain aging. Mechanisms of Ageing and Development, 161(Pt A), 37-50. [CrossRef]
• 71. Végh, M.J., Waard, M.C.D., Plujim, I.V.D., Ridwan, Y., Sassen, M.J.M., Nierop, P.V., Schors, R.C.V.D., Li, K.W., Hoeijlmakers, J.H.J., Smit, A.B., Kesteren, R.E.V. (2012). Synaptic proteome changes in a DNA repair deficient ercc1 mouse model of accelerated aging. Journal of Proteome Research, 11(3), 1855-67. [CrossRef]
• 72. Fjell, A.M., Walhovd, K.B. (2010). Structural brain changes in aging: courses, causes and cognitive consequences. Reviews in the Neurosciences, 21(3), 187-221. [CrossRef]
• 73. Isaev, N.K., Stelmashook, E.V., Genrikhs, E.E. (2019). Neurogenesis and brain aging. Reviews in the Neurosciences, 30(6), 573-580. [CrossRef]
• 74. Ahlenius, H., Visan, V., Kokaia, M., Lindvall, O., Kokaia, Z. (2009). Neural stem and progenitor cells retain their potential for proliferation and differentiation into functional neurons despite lower number in aged brain. Journal of Neuroscience, 29(14), 4408-4419. [CrossRef]
• 75. Cameron, H.A., Glover, L.R. (2015). Adult neurogenesis: beyond learning and memory. Annual Review of Psychology, 66, 53-81. [CrossRef]
• 76. Enwere, E., Shingo, T., Gregg, C., Fujikawa, H., Ohta, S., Weiss, S. (2004). Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination. The Journal of Neuroscience, 24(38), 8354-8365. [CrossRef]
• 77. Drapeau, E., Mayo, W., Aurousseau, C., Le Moal, M., Piazza, P.V., Abrous, D.N. (2003). Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proceedings of the National Academy of Sciences of the United States of America, 100(24), 14385-14390. [CrossRef]
• 78. Jin, W.N., Shi, K., He, W., Sun, J.H., Van Kaer, L., Shi, F.D., Liu, Q. (2021). Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition. Nature Neuroscience, 24(1), 61-73. [CrossRef]